CoChat

Epidemiology of Severe Myoclonic Epilepsy of Infancy

Hurst, Daniel L. · 1990 · Epilepsia
Cited by 124

The DOI matches its Crossref record.

Abstract

Summary: Severe myoclonic epilepsy of infancy (SMEI) is a newly recognized epileptic syndrome. It is characterized by multiple febrile seizures, often prolonged, subsequent development of uncontrollable mixed‐myoclonic seizures, and, eventually, psychomotor retardation. Drugs for myoclonic epilepsy–valproate (VPA), the suximides, and the benzodiazepines–have been shown to be useful in SMEI. Among children with seizures in the National Institute of Neurological and Communicative Disorders and Stroke Collaborative Perinatal Project (NCPP), one individual with SMEI was identified. This finding from the NCPP suggests that the incidence of SMEI is ∽1 in 40,000 children. Such an incidence is supported by observations at the Texas Tech University Health Sciences Center. RÉSUMÉ: L'épilepsie myoclonique sévère du nourrisson (EMSN) est un syndrome épileptique d'individualisation récente. II est caractérisé par des crises fébriles multiples, souvent prolongées, avec installation secondaire de crises à composante myoclonique difficiles à contrôler et d'un retard psychomoteur. Les médicaments de l'épilepsie myoclonique (valproate, succimides, benzodiazépines) sont utiles dans le traitement de l'EMSN. Parmi les enfants ayant présenté des crises, pris en charge dans le projet collaboratif péri‐natal de l'Institut National des Maladies Neurologiques et de la Communication et des Maladies Vasculaires (NCPP), les auteurs ont identifié un patient présentant une EMSN. Cette constatation suggère que l'incidence de l'EMSN est d' environ 1 pour 40,000 enfants. Une telle incidence est confirmée par les observations effectuées au Centre Médical de l'Université Technologique du Texas. RESUMEN: La epilepsia mioclónica severe de la infancia (SMEI) es un síndrome reconocido recientemente. Se caracteriza por múltiples ataques febriles, frecuentemente prolongados. desarrollo subsiguiente de ataques combinados de myoclonias que son incontrolables y, eventualmente, de retraso pskomotor. Las medicación para la epilepsia mioclónica: el valproate Us suximidas y las benzodiazepinas, han demostrado ser eficaces en el SMEI. Entre los niños con ataques que se incluyeron en el proyecto del Instituto Nacional de Trastornos Neurológicos y de U Comunicación y en el Estudio Colaborativo del Institute Perinatal (NCPP) se identificó un individuo con SMEI. Este hallazgo en el NCPP sugiere que la incidencia de la SMEI es aproximadamente 1 en 40,000. Esta incidencia es semejante a la observada en el Centra de Ciencias de la Salud de la Universidad Technológica de Texas. ZUSAMMENFASSUNG: Die sebwere frühkindliche myoklonische Epilepsie (SME) ist ein neuerkanntes epileptisches Syndrom. Es wird charakterisiert durch rezidivierende, oft prolongierte Fieberkrärnpfe mit nachfolgend sich entwickelnden gemischten m yoklomschen Anfällen und möglicher psychomotorischer Retardierung. Für die Behandlung erweisen sich Medikamente für myoklonische Epilepsien als wirksam wie Valproat, Suximide, Benzodiazepine, Unter den Kindern mit Anfällen fand sich eines mit einer SME im National Institute of Neurological and Communicative Disorders und in dem Stroke collaborative Perinatal Project (NCPP). Dieses Ergebnis des NCPP läβt eine annähernde Schätzung der Inzidenz der SME mit 1/40,000 zu. Diese Inzidenz wird durch die Beobachtungen an der Texas Tech. University Health Sciences Center bestätigt.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1528-1157.1990.tb05494.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 124

Metadata

Authors
Hurst, D. L.
Venue
Epilepsia
Publisher
Wiley
Published
1990-08
Volume
31
Issue
4
Pages
397-400
ISSN
  • 0013-9580 (ISSN-L)
  • 1528-1167
OpenAlex
W1991286554
Cited by
124
References
0
FWCI
0.36
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Epidemiology of Severe Myoclonic Epilepsy of Infancy. https://app.cochat.ai/papers/10.1111/j.1528-1157.1990.tb05494.x
The paper
Hurst, D. L. (1990). Epidemiology of Severe Myoclonic Epilepsy of Infancy. Epilepsia. https://doi.org/10.1111/j.1528-1157.1990.tb05494.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.